These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 3145994

  • 1. [Improvement in anti-hemophilic preparations and its problems. 2. Inadequacy of the heat treatment of factor concentrates on the inactivation of non-A, non-B hepatitis virus].
    Inagaki M, Osano M.
    Rinsho Ketsueki; 1988 May; 29(5):635-9. PubMed ID: 3145994
    [No Abstract] [Full Text] [Related]

  • 2. [Improvement in anti-hemophilic preparations and arts problems. 1. Heat-treated concentrates].
    Ikematsu S, Yorifuji H, Arai M, Fukutake K.
    Rinsho Ketsueki; 1988 May; 29(5):628-34. PubMed ID: 3145993
    [No Abstract] [Full Text] [Related]

  • 3. Non-A, non-B hepatitis associated with a factor IX complex infused during cardiovascular surgery--Arizona.
    Centers for Disease Control (CDC).
    MMWR Morb Mortal Wkly Rep; 1986 Jun 20; 35(24):391-4, 399. PubMed ID: 3086697
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Heat treatment at 100 degrees C of factor VIII and IX coagulation factor concentrates.
    Teh LC, Woodfield DG.
    Med J Aust; 1993 Sep 06; 159(5):355-6. PubMed ID: 8361441
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Inactivation and clearance of viruses during the manufacture of high purity factor IX.
    Johnston A, Macgregor A, Borovec S, Hattarki M, Stuckly K, Anderson D, Goss NH, Oates A, Uren E.
    Biologicals; 2000 Sep 06; 28(3):129-36. PubMed ID: 10964439
    [Abstract] [Full Text] [Related]

  • 15. Immunoprophylaxis of non-B hepatitis (hepatitis A and non-A non-B hepatitis).
    Spector R.
    J Iowa Med Soc; 1982 Mar 06; 72(3):112-3, 118. PubMed ID: 6802909
    [No Abstract] [Full Text] [Related]

  • 16. Dry-heat treatment process for enhancing viral safety of an antihemophilic factor VIII concentrate prepared from human plasma.
    Kim IS, Choi YW, Kang Y, Sung HM, Shin JS.
    J Microbiol Biotechnol; 2008 May 06; 18(5):997-1003. PubMed ID: 18633304
    [Abstract] [Full Text] [Related]

  • 17. Virucidal treatment of clotting factor concentrates.
    Mannucci PM, Colombo M.
    Lancet; 1988 Oct 01; 2(8614):782-5. PubMed ID: 2901620
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.